Clinical Trial Update: Natural Killer Cells and Bortezomib to Treat Cancer [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial update reports on the combination of natural killer cells and bortezomib for several cancers, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Colorectal Cancer
• Multiple Myeloma
• Non-small Cell Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• Bortezomib (bortezomib)
• Natural killer cells (natural killer cells)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Chronic Myeloid Leukemia (CML), Pancreatic Ca | Phase 1 | Status: COMPLETED